Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults. - Wikidata - wikimedia - TriplyDB

Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults.

Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults.

http://www.wikidata.org/entity/Q35093445

about

Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens.A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe.Measuring naturally acquired ex vivo IFN-γ responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults.Natural antibody response to Plasmodium falciparum merozoite antigens MSP5, MSP9 and EBA175 is associated to clinical protection in the Brazilian Amazon.Measurement of ex vivo ELISpot interferon-gamma recall responses to Plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria Acquired immune responses to three malaria vaccine candidates and their relationship to invasion inhibition in two populations naturally exposed to malaria.Acquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western Thailand.Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.The Threshold of Protection from Liver-Stage Malaria Relies on a Fine Balance between the Number of Infected Hepatocytes and Effector CD8+ T Cells Present in the Liver Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation.Polymorphism in liver-stage malaria vaccine candidate proteins: immune evasion and implications for vaccine design.A flow cytometry-based workflow for detection and quantification of anti-plasmodial antibodies in vaccinated and naturally exposed individuals.High-Density Peptide Arrays for Malaria Vaccine Development.Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system.How Can Elispot Add Information to Improve Knowledge on Tropical Diseases?[Profiles of IgG responses against CSP, GLURP and LSA-3NR2 in urban malaria (Dakar): relations with haemoglobin levels and parasite densities].Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area.[IgG responses to candidate malaria vaccine antigens in the urban area of Dakar (Senegal): evolution according to age and parasitemia in patients with mild symptoms].

P2860

Q21034050-7D695BE0-433E-4D78-8D00-A95AA2B58E72 Q27972709-42585F36-F825-4466-8560-2E94219667FF Q34209043-E50A19FD-D347-4725-8D81-A0D2E35A1FCA Q34541330-A82550DD-F06F-4FFD-8F32-F84F8952D93F Q34792326-584E8F87-ACD3-4843-989D-F8925F046003 Q35021277-4E34C6BE-CB2A-4E15-9605-A48669DB83B7 Q35076906-611FB0B3-B173-49A8-9EE5-7261DC558B77 Q36531046-0E6ECBCD-BF0E-4125-A37C-0083906C3F63 Q36550447-5E3A1C66-0804-46A4-B81A-8117BC97B8E2 Q36555051-48E5CA6E-FD4A-4B1C-A867-1201397E5CED Q36694820-7CE47FD5-07DC-4288-8BD5-57DB5161ECCA Q37040808-BC50269D-5D43-49C7-96D2-7CFC3088B22B Q37118222-42D2C1ED-C677-4AF0-8046-4929791C83E4 Q37643867-39C7933D-9208-4E7B-9CC9-DDEFB4EBBFC7 Q37654676-102345B8-0360-41A4-881B-F8E8343F9397 Q37716319-44349DD4-FE91-42BE-A5AD-3686436007E7 Q38648583-D1AD0598-F5BD-4367-A28F-11C77F270904 Q38864802-0B44A881-320E-44E0-A0DE-519C2BAD3703 Q40715694-FC67E83C-81C9-41D5-93A3-8FAE8CC3FAD1 Q41927939-12509CFE-4A42-4CA4-9E75-DA0A0441D514 Q41928044-D2C8BA8F-7550-4293-B48F-C0548933970C Q46299460-7496D7BD-F9C0-4F63-827D-B7DF55839D9D Q46758381-2291EF86-4072-4B6F-BD36-710221049F03 Q47912581-FD07F5EF-3E5F-47C9-B31A-F8E8DF190238

P2860

Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults.

http://www.wikidata.org/entity/Q35093445

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Measuring naturally acquired i ...... e antigens in Ghanaian adults.

@ast

Measuring naturally acquired i ...... e antigens in Ghanaian adults.

@en

type

label

Measuring naturally acquired i ...... e antigens in Ghanaian adults.

@ast

Measuring naturally acquired i ...... e antigens in Ghanaian adults.

@en

prefLabel

Measuring naturally acquired i ...... e antigens in Ghanaian adults.

@ast

Measuring naturally acquired i ...... e antigens in Ghanaian adults.

@en

P1433

Q35093445-32CB7458-EC28-4EF7-BDE3-52386CEE0BC9

P1476

Q35093445-E5C0E664-5A51-468A-AD82-B3665CE25082

P2093

Q35093445-060CBCD6-F8C7-40CC-ABB0-A25052F3A363

Q35093445-11F41B17-09F1-4DB0-B95C-B756FD03840E

Q35093445-28662A49-B6FC-4AC4-851F-CE2974704FE5

Q35093445-32349DFF-F21B-4274-9284-53C81B067F57

Q35093445-335598D6-0E09-4098-87AF-77382C027612

Q35093445-36D218B4-5FD4-47D7-A4BC-207CF37F612A

Q35093445-52A9044E-CF72-458F-B09A-504D2BA6E362

Q35093445-636828E6-2C6A-46B5-9BB8-C405A5538C6A

Q35093445-7146AD89-BECE-427D-8100-D0E489C18D8C

Q35093445-87525CD2-0BCC-47FB-AB66-06D899C3A288

P2860

Q35093445-01382973-623A-4CF0-9046-29D312A004B3

Q35093445-02D23548-742A-4E9E-AC81-05A39C8C2108

Q35093445-0659C9F9-1322-40C0-BDF7-075250F45C3F

Q35093445-0BE039FD-AFFC-495C-B0F4-EBC832367E12

Q35093445-0E8B55F8-5928-40B3-B244-973ED52348C2

Q35093445-1D8BAEA4-2D33-448B-A9B4-64713D09B56B

Q35093445-2A421CAC-53DF-4E84-B0E5-364D48FA2439

Q35093445-2F19A81D-7E68-43A7-8B20-39F4D2195AB1

Q35093445-303EBE87-960D-41C6-AE90-930FB934A3D9

Q35093445-30C91F11-3032-4D9D-81DA-9A8CE216CE30

P2888

Q35093445-823CF649-BC66-4DB6-BBC5-06163342DF57

P304

Q35093445-3730DEFA-62E2-4F13-A85D-BCF9F69C34B8

P31

Q35093445-2F29A481-5A10-472C-ABBE-8C3966A8F7A3

P356

Q35093445-8DB22568-35C6-4FAB-B0B4-1C46F36C8A71

P478

Q35093445-3339A7C8-B680-4E6D-B5FC-B80BAC99CFE7

P50

Q35093445-53E853AA-3F6D-45F9-AFCE-738425967E18

Q35093445-74BA90D7-7C78-4899-950B-A4597399F78C

Q35093445-B9C0761A-8CE1-4232-87AE-70A51333B976

Q35093445-C9C4F6B6-E6B3-4C05-8777-4CF1D8EBF2F6

P577

Q35093445-A9F990C6-1986-4406-B0DF-E7E0CAEB8A07

P5875

Q35093445-CF44B35E-AEE6-41CE-B98B-BE8843054381

P6179

Q35093445-CD199227-A165-4CA7-B342-2AF1B6ABC640

P698

Q35093445-52C9BB8F-0E4A-44E3-B2AE-6C99FC4BFDFE

P921

Q35093445-9D5F7881-B597-4EFF-90EA-343481A9C871

P932

Q35093445-1D66BC56-02B2-44FB-928F-7FE19315F840

P356

1475-2875-10-168

P1433

Malaria Journal

P1476

Measuring naturally acquired i ...... e antigens in Ghanaian adults.

@en

P2093

Bartholomew D Akanmori

http://www.w3.org/2001/XMLSchema#string

Ben Gyan

http://www.w3.org/2001/XMLSchema#string

Denise L Doolan

http://www.w3.org/2001/XMLSchema#string

Donald Brambilla

http://www.w3.org/2001/XMLSchema#string

Dorothy Anum

http://www.w3.org/2001/XMLSchema#string

Esteban Abot

http://www.w3.org/2001/XMLSchema#string

Glenna Banania

http://www.w3.org/2001/XMLSchema#string

Harini Geneshan

http://www.w3.org/2001/XMLSchema#string

Jennylyn Legano

http://www.w3.org/2001/XMLSchema#string

Josephine Ocran

http://www.w3.org/2001/XMLSchema#string

P2860

Acquired immunity to malaria

Cellular responses to Plasmodium falciparum erythrocyte membrane protein-1: use of relatively conserved synthetic peptide pools to determine CD4 T cell responses in malaria-exposed individuals in Benin, West Africa

Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens

HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles.

Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults

Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.

The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.

Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule

Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining.

Allele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria.

P2888

1475-2875-10-168

P304

168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2875-10-168

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Thomas L. Richie

Susan Adu-Amankwah

P577

2011-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51234792

http://www.w3.org/2001/XMLSchema#string

P6179

1043645027

http://www.w3.org/2001/XMLSchema#string

P698

21689436

http://www.w3.org/2001/XMLSchema#string

P921

P932

3132199

http://www.w3.org/2001/XMLSchema#string